NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach

Free Radic Biol Med. 2012 Jan 15;52(2):291-7. doi: 10.1016/j.freeradbiomed.2011.10.482. Epub 2011 Nov 3.

Abstract

Heart failure (HF) occurs when the adaptation mechanisms of the heart fail to compensate for stress factors, such as pressure overload, myocardial infarction, inflammation, diabetes, and cardiotoxic drugs, with subsequent ventricular hypertrophy, fibrosis, myocardial dysfunction, and chamber dilatation. Oxidative stress, defined as an imbalance between reactive oxygen species (ROS) generation and the capacity of antioxidant defense systems, has been authenticated as a pivotal player in the cardiopathogenesis of the various HF subtypes. The family of NADPH oxidases has been investigated as a key enzymatic source of ROS in the pathogenesis of HF. In this review, we discuss the importance of NADPH oxidase-dependent ROS generation in the various subtypes of HF and its implications. A better understanding of the pathogenic roles of NADPH oxidases in the failing heart is likely to provide novel therapeutic strategies for the prevention and treatment of HF.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetic Cardiomyopathies / enzymology
  • Diabetic Cardiomyopathies / etiology
  • Diabetic Cardiomyopathies / prevention & control
  • Doxorubicin / adverse effects
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Heart Failure / enzymology*
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / prevention & control
  • Humans
  • Hypertension / complications
  • Myocarditis / complications
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • Oxidative Stress*
  • Reactive Oxygen Species / metabolism
  • Ventricular Remodeling

Substances

  • Enzyme Inhibitors
  • Reactive Oxygen Species
  • Doxorubicin
  • NADPH Oxidases